Konstantinos Balaskas and Anitta Sharma discuss the HERMES trial, a cluster-randomised controlled trial investigating teleophthalmology innovations versus standard of care, including real-world implications of the AI involved and potential directions for future research and practice.

Click here to read our latest issue

Follow us today at...

https://bsky.app/profile/lancetprimarycare.bsky.social

https://www.linkedin.com/company/the-lancet

https://instagram.com/thelancetgroup

https://facebook.com/thelancetmedicaljournal

https://youtube.com/thelancettv